At the University of Oxford, Justin Benesch studies assemblies made between proteins called molecular chaperones and the proteins they protect in cells. These assemblies slow the formation of amyloid ...

"our target revenue of $200 million has not changed" (Chairman & CFO Brett Moyer). "We ended the quarter with a very exciting $800 million in tokenization contracts signed. These contracts are tied to ...